Improving the immunogenicity and protective efficacy of a whole-killed malaria blood-stage vaccine by chloroquine
Improving the immunogenicity and protective efficacy of a whole-killed malaria blood-stage vaccine by chloroquine
复制标题
氯喹提高全灭活疟疾血期疫苗的免疫原性和保护功效
DOI:
10.1111/pim.12682
复制
发表时间:
2020
影响因子:
2.2
通讯作者:
Xu Wenyue
中科院分区:
文献类型:
--
作者:
Fu Yong;Lu Xiao;Zhu Feng;Zhao Yunxiang;Ding Yan;Ye Lilin;Guo Bo;Liu Taiping;Xu Wenyue
A whole‐killed malaria blood‐stage vaccine (WKV) is promising in reducing the morbidity and mortality of malaria patients, but its efficacy needs to be improved. We found that the antimalarial drug chloroquine could augment the protective efficacy of the WKV ofPlasmodium yoelii. The direct antimalarial effect of chloroquine on parasites during immunization could be excluded, as the administration of chloroquine or chloroquine plus alum every two weeks had a slight effect on parasitemia, and an immunization with NP‐KLH (4‐hydroxy‐3‐nitrophenylacetyl Keyhole Limpet Hemocyanin) plus chloroquine could significantly promote the generation of NP‐specific antibodies. Additionally, alum was required for chloroquine to augment the immunogenicity of the pRBC lysate. Chloroquine did not promote the parasite‐specific CD4+T‐cell responses, but significantly enhanced the WKV‐induced germinal centre B cell reactions, class‐switch recombination and secretion of functionally protective antibodies toplasmodium. The elevated parasite‐specific antibodies were demonstrated to largely contribute to the chloroquine‐enhanced protective immunity. Thus, we report that chloroquine could be used as an adjuvant to enhance the protective immunity of WKVs through promoting humoral responses.